Non-Invasive Prenatal Testing

Diagnostic prenatal tests, such as chorionic villus sampling and amniocentesis, are highly accurate but carry a 0.5 – 1.5 % risk of miscarriage. While maternal screening serum tests negate this risk, they typically carry a 5% chance of false-positive results.

PRENITA™ NIPT combines the merits of both techniques by negating the risk of miscarriage and reducing the chance of false-positive results.

With greater sensitivity and specificity of PRENITA™ NIPT, it is expected that the number of women undergoing unnecessary invasive testing will be reduced.

PRENITA™ NIPT is the most advanced, non-invasive prenatal screening test. With just 10 ml of maternal blood, we can analyse every chromosome to check for genetic conditions that could affect your baby’s health.

Following analysis, PRENITA™ NIPT provides a genetic score for the conditions tested:

• Low risk: Unlikely that the baby is affected by the tested genetic conditions
• High risk: Increased risk that the baby has a genetic condition – further testing required to confirm.

There are several benefits of choosing PRENITA™ NIPT over other prenatal screening techniques, including:

✓   Early detection at 10 weeks
✓   Reduced risk of false positives
✓   Increased sensitivity and specificity
✓   Short turnaround time of 10 days
✓   Information on every chromosome

REPROCELL) also offer follow-up services to PRENITA™ NIPT, including personalized genetic counselling and confirmatory tests for high risk pregnancies.

PRENITA™ NIPT can be offered to any expectant mother who wants information on the genetic condition of her baby, and is recommended to expectant mothers with:

✓   Advanced maternal age
✓   Positive maternal serum screen
✓  Abnormal ultrasound findings
✓  Positive personal or family history

If you are unsure whether PRENITA™ NIPT is right for you, or if you require further information, speak to your healthcare provider or download our FAQs document.